Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Polymer Chemistry Innovations (PCI) is a specialty polymer manufacturer that provides high-performance materials for the pharmaceutical, biotechnology, and medical device industries. The company is best known for its proprietary production of Aquazol (poly(2-ethyl-2-oxazoline)), a highly versatile, water-soluble polymer used extensively in drug delivery systems, medical adhesives, and as a biocompatible alternative to polyethylene glycol (PEG). PCI operates state-of-the-art manufacturing facilities that support custom polymerization and large-scale production under cGMP standards. By offering unique monomers and polymers with tailored properties, the company enables the development of advanced therapeutic formulations and innovative medical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Polymer Chem.